| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/11/1991 | WO1991009948A1 Rice actin gene and promoter |
| 07/11/1991 | WO1991009876A1 Radiolabeled proteins for diagnostic or therapeutic use |
| 07/11/1991 | WO1991009873A1 New proteins |
| 07/11/1991 | WO1991009872A2 Hiv-1 env fragment fusion protein |
| 07/11/1991 | WO1991009870A1 Immunologically active proteines from borrelia burgdorferi, related test kits and vaccine |
| 07/11/1991 | WO1991009867A1 Mucin nucleotides |
| 07/11/1991 | WO1991009866A1 Papillomavirus (hpv63) probe, particularly for the in vitro diagnosis of papillomavirus infections, possibly accompanied by genital neoplasias, and products genetically and immunologically linked to this papillomavirus |
| 07/11/1991 | WO1991009628A1 Use of an anticoagulant as a diagnostic agent |
| 07/11/1991 | WO1991009623A1 Diagnosis and treatment of diseases |
| 07/11/1991 | WO1991009621A1 PEPTIDE FRAGMENT COMPRISING A SEQUENCE FROM THE 28kDa PROTEIN OF SCHISTOSOMA MANSONI, AND VACCINATING AND/OR THERAPEUTIC COMPOSITIONS COMPRISING SAID FRAGMENT |
| 07/11/1991 | WO1991009620A1 ANTIGENIC sTA PROTEIN PRESENT ON CELLS, CORRESPONDING ANTIBODIES, AND USES THEREOF |
| 07/11/1991 | WO1991009615A1 Polyhemoglobin stabilized by purine derivatives and glutathione |
| 07/11/1991 | CA2073436A1 Preparation exhibiting enzymatic delignification activity, a method of producing the same, and applications thereof |
| 07/11/1991 | CA2072356A1 Diagnosis and treatment of diseases |
| 07/10/1991 | WO1991010681A1 Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues |
| 07/10/1991 | EP0436467A2 Expression of S-locus specific glycoprotein gene in transgenic plants |
| 07/10/1991 | EP0436400A1 Intracelluar antigen found in subpopulation of CD8+T lymphocytes and monoclonal antibody reactive with same |
| 07/10/1991 | EP0436266A1 Process for the production of gelatin from fish skins |
| 07/10/1991 | EP0436189A1 Endothelin atagonistic cyclic pentapeptides |
| 07/10/1991 | EP0436086A1 Isolation of alpha-1-antitrypsin from human plasma and construction of a kit useful for detecting alpha 1-antitrypsin levels in blood |
| 07/10/1991 | EP0436003A1 Production of heterologous proteins in plants and plant cells |
| 07/10/1991 | EP0435996A1 MODIFIED TRANSFORMING GROWTH FACTOR $g(a) OLIGOPEPTIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF |
| 07/10/1991 | EP0435957A1 Dna damage-binding factor and uses therefor |
| 07/10/1991 | EP0435948A1 Crf antagonists |
| 07/10/1991 | EP0435946A1 Methods for modifying the binding of cell adhesion receptors. |
| 07/10/1991 | EP0435887A1 Renin inhibitory peptides containing maleamide substituents |
| 07/10/1991 | EP0435877A1 Polynucleotides that encode the human proteoglycan peptide core of the effector cells of the immune response |
| 07/10/1991 | EP0218622B1 Amides of para-methoxycinnamic and utilization thereof as solar filters |
| 07/10/1991 | CN1052897A Subtilisin mutants |
| 07/10/1991 | CN1052896A Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
| 07/10/1991 | CN1052868A Stabilization and maintenance of nerve growth factor biological activity by use of natural gangliosides or derivatives thereof |
| 07/10/1991 | CN1013120B Improved process for producing a-21978c derivative |
| 07/10/1991 | CA2072253A1 Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues |
| 07/10/1991 | CA2031984A1 Glidobactin pf-1 peptide antitumor antibiotics |
| 07/09/1991 | WO1991010684A1 Oxidized variants of gm-csf |
| 07/09/1991 | US5030723 Long-chain glycolipid structure |
| 07/09/1991 | US5030722 Odorant-binding protein from rat |
| 07/09/1991 | US5030720 Pres2+S hepatitis B vaccine derived from plasma |
| 07/09/1991 | US5030718 Against htlc, in pure form |
| 07/09/1991 | US5030716 Methods and compositions employing interferon-gamma |
| 07/09/1991 | US5030715 Antibacterial agents; immunomodulators; auto immune diseases |
| 07/09/1991 | US5030714 Isolated or synthetic peptide; diagnosis of aids |
| 07/09/1991 | US5030621 Vaccine for treatment of human melanoma; cultures of human melanoma cell lines; determining molecular weight |
| 07/09/1991 | US5030578 Serum protein removal, chromatography |
| 07/09/1991 | US5030576 For screening drugs, immunoassays |
| 07/09/1991 | US5030564 Monoclonal antibody specific to the lymphokine LK 2 and its method of production |
| 07/09/1991 | US5030563 Bacterial hypersecretion using mutant repressor sequence |
| 07/09/1991 | US5030559 Methods and compositions for the identification of metastatic human tumors |
| 07/09/1991 | US5030556 Species-specific DNNA probe for the detection of Branhamella catarrhalis |
| 07/09/1991 | US5030449 Synthetic vaccine against AIDS virus |
| 07/09/1991 | CA2072587A1 Oxidized variants of gm-csf |
| 07/09/1991 | CA1285895C Yeast production of hepatitis b surface antigen |
| 07/06/1991 | WO1991009874A1 Novel fibronectin receptor |
| 07/06/1991 | WO1991009869A1 Hiv-1 core protein fragments |
| 07/06/1991 | CA2072351A1 Hiv-1 core protein fragments |
| 07/06/1991 | CA2072013A1 Fibronectin receptor |
| 07/06/1991 | CA2033644A1 Intracellular antigen found in subpopulation of cd8+t lymphocytes and monoclonal antibody reactive with same |
| 07/06/1991 | CA2033535A1 Method for preparing a dried composition of insulin-like growth factor i |
| 07/05/1991 | WO1991009614A1 GPIbα FRAGMENTS AND RECOMBINANT DNA EXPRESSION VECTORS |
| 07/05/1991 | CA2072753A1 Gpi.beta.o fragments and recombinant dna expression vectors |
| 07/04/1991 | DE4040817A1 New labelled annexin type anticoagulant polypeptide(s) - able to differentiate between phosphatidyl choline and phosphatidyl serine, for early detection of prothrombotic states etc. |
| 07/03/1991 | WO1991009949A1 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
| 07/03/1991 | EP0435845A1 Reagent and method for determining activity of retroviral protease |
| 07/03/1991 | EP0435776A1 Artificial promoter for protein expression in yeast |
| 07/03/1991 | EP0435617A1 Bovine myogenic factor gene |
| 07/03/1991 | EP0435229A1 DNA of non-A, non-B hepatitis virus gene, its clone and use thereof |
| 07/03/1991 | EP0434992A1 Enteroviral polypeptide and group-specific detection of enterovirus infection |
| 07/03/1991 | EP0434979A1 Peptide derivatives useful as antagonists of bombesin and gastrin-releasing peptide |
| 07/03/1991 | EP0434909A2 Anticoagulant and antihelminthic proteins and methods for the production and use of same |
| 07/03/1991 | EP0434836A1 Method for purifying tenascin |
| 07/03/1991 | EP0434751A1 A malaria antigen |
| 07/03/1991 | EP0434747A1 Viral vaccines |
| 07/03/1991 | EP0434744A1 Serum immunoregulatory polypeptide and uses therefor. |
| 07/03/1991 | EP0434727A1 Red-shifted phthalocyanine and tetrabenztriazaporphyrin reagents |
| 07/03/1991 | EP0434721A1 Viral nucleotide sequences |
| 07/03/1991 | EP0434718A1 Peptide compounds |
| 07/03/1991 | EP0434685A1 Gram-negative bacterial endotoxin blocking monoclonal antibodies |
| 07/03/1991 | EP0398925A4 Growth inhibiting agent and the use thereof |
| 07/03/1991 | EP0151128B1 Monoclonal antibodies reactive with endotoxin core |
| 07/03/1991 | CN1052608A Bcrfl proteins as inhibitors of interferon-gamma |
| 07/03/1991 | CN1052607A Cell cycle-dependent regulation of phosphorylation of human retion blastoma gene product |
| 07/02/1991 | US5028697 Antitumor agents, cell specific |
| 07/02/1991 | US5028694 Antigenic proteins and vaccines containing them for prevention of coccidiosis caused by eimeria Eimeria necatrix and Eimeria tenella |
| 07/02/1991 | US5028692 Gastrin releasing peptide antagonist |
| 07/02/1991 | US5028626 Peptides with pharmaceutical activity |
| 07/02/1991 | US5028588 Blood substitutes |
| 07/02/1991 | US5028587 Containing arg-b31 and/or arg2-(b31-32) human insulin; antidiabetic agents |
| 07/02/1991 | US5028586 Eliminating some or all of the acid containing side chains by esterification or replacement of glutamic acid residues with glutamine, prolonged action |
| 07/02/1991 | US5028534 DNA clones of human placental plasminogen activator inhibitor |
| 07/02/1991 | US5028533 Precursor polypeptide, DNA sequence coding therefor, vectors host organisms, and processes involving same |
| 07/02/1991 | US5028531 Escherichia culture product; fused to methionine terminal acid of peptide |
| 07/02/1991 | US5028530 AraB promoters and method of producing polypeptides, including cecropins, by microbiological techniques |
| 07/02/1991 | US5028426 Deletion mutant of pseudorabies virus and vaccine containing said virus |
| 07/02/1991 | US5028425 Synthetic vaccine against P. falciparum malaria |
| 07/02/1991 | US5028424 Antibodies to receptor and antigen for natural killer and non-specific cytotoxic cells |
| 07/02/1991 | US5028421 Method of treating birds |
| 07/02/1991 | US5028420 Muteins of tumor necrosis factor |
| 07/02/1991 | CA1285699C Process for solubilization, purification and characterization ofprotein from insoluble protein aggregates or complexes and compositions of matter therefrom |
| 07/02/1991 | CA1285507C Hybrid interferons |
| 07/02/1991 | CA1285505C Stable dna constructs containing as selectable markers, genes whose products are essential for normal cell growth on complex media |